Novel Therapies for the Treatment of Central Sleep Apnea

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Sleep Medicine Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Javaheri S.
        • Dempsey J.A.
        Central sleep apnea.
        Compr Physiol. 2013; 3: 141-163
      1. Javaheri S. Heart failure. In: Kryger MH, Roth T, Dement WC, editors. Principles and practices of sleep medicine. 6th edition. Philadelphia: WB Saunders, in press.

        • Dowdell W.T.
        • Javaheri S.
        • McGinnis W.
        Cheyne-Stokes respiration presenting as sleep apnea syndrome. Clinical and polysomnographic features.
        Am Rev Respir Dis. 1990; 141: 871-879
        • Javaheri S.
        • Sands S.A.
        • Edwards B.A.
        Acetazolamide attenuates Hunter-Cheyne-Stokes breathing yet paradoxically augments the hypercapnic ventilatory response in patients with heart failure.
        Ann Am Thorac Soc. 2014; 11: 80-86
        • Khayat R.
        • Abraham W.
        • Patt B.
        • et al.
        Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure.
        J Cardiol. 2012; 18: 534-540
        • Javaheri S.
        • Shukla R.
        • Zeigler H.
        • et al.
        Central sleep apnea, right ventricular dysfunction and low diastolic blood pressure are predictors of mortality in systolic heart failure.
        J Am Coll Cardiol. 2007; 49: 2028-2034
        • Javaheri S.
        • Caref B.
        • Chen E.
        • et al.
        Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure.
        Am J Respir Crit Care Med. 2011; 183: 539-546
        • Bitter T.
        • Faber L.
        • Hering D.
        • et al.
        Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction.
        Eur J Heart Fail. 2009; 11: 602-608
        • Herrscher T.E.
        • Akre H.
        • Øverland B.
        • et al.
        High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function.
        J Card Fail. 2011; 17: 420-425
        • Khayat R.
        • Jarjoura D.
        • Patt B.
        • et al.
        In-hospital testing for sleep-disordered breathing in hospitalized patients with decompensated heart failure: report of prevalence and patient characteristics.
        J Card Fail. 2009; 15: 739-746
        • Javaheri S.
        Heart failure.
        in: The encyclopedia of sleep. vol. 3. Academic Press, Waltham (MA)2013: 374-386
        • Javaheri S.
        • Brown L.
        • Randerath W.
        Positive airway pressure therapy with adaptive servo-ventilation (part II: clinical applications).
        Chest. 2014; 146: 855-868
        • Javaheri S.
        • Abraham W.T.
        • Brown C.
        • et al.
        Prevalence of obstructive sleep apnea and periodic limb movement in 45 subjects with heart transplantation.
        Eur Heart J. 2004; 25: 260-266
        • Ponikowski P.
        • Javaheri S.
        • Michalkiewicz D.
        • et al.
        Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure.
        Eur Heart J. 2012; 33: 889-894
        • Bradley T.
        • Logan A.
        • Kimoff J.
        • et al.
        Continuous positive airway pressure for central sleep apnea and heart failure.
        N Engl J Med. 2006; 353: 2025-2033
        • Javaheri S.
        CPAP should not be used for central sleep apnea in congestive heart failure patients.
        J Clin Sleep Med. 2006; 2: 399-402
        • Javaheri S.
        Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure.
        Circulation. 2000; 101: 392-397
        • Arzt M.
        • Floras J.S.
        • Logan A.G.
        • et al.
        Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure. A post-hoc analysis of the Canadian Continuous Positive Airway Pressure for patients with central sleep apnea and heart failure trial (CANPAP).
        Circulation. 2007; 115: 3173-3180
        • Ryan C.M.
        • Floras J.S.
        • Logan A.G.
        • et al.
        Shift in sleep apnoea type in heart failure patients in the CANPAP trial.
        Eur Respir J. 2010; 35: 592-597
        • Javaheri S.
        • Brown L.
        • Randerath W.
        Positive airway pressure therapy with adaptive servoventilation (part 1: operational algorithms).
        Chest. 2014; 146: 514-523
        • Brown L.K.
        • Javaheri S.
        Adaptive servoventilation for the treatment of central sleep apnea in congestive heart failure: what have we learned?.
        Curr Opin Pulm Med. 2014; 20: 550-557
        • Sogol J.
        • Shahrokh J.
        Nocturnal noninvasive ventilation in heart failure.
        in: Basner R.C. Parthasarathy S. Nocturnal non-invasive ventilation: theory, evidence, and practice. Springer Science, New York2015: 73-81
        • Randerath W.J.
        • Javaheri S.
        Adaptive servo-ventilation in central sleep apnea.
        Sleep Med Clin. 2014; 9: 69-85
        • Cowie M.R.
        • Woehrle H.
        • Wegscheider K.
        • et al.
        Adaptive servo-ventilation for central sleep apnea in systolic heart failure.
        N Engl J Med. 2015; 373: 1095-1105
        • Ramar K.
        • Ramar P.
        • Morgenthaler T.I.
        Adaptive servoventilation in patients with central or complex sleep apnea related to chronic opioid use and congestive heart failure.
        J Clin Sleep Med. 2012; 8: 569-576
        • Zhang X.L.
        • Ding N.
        • Wang H.
        • et al.
        Transvenous phrenic nerve stimulation in patients with Cheyne-Stokes respiration and congestive heart failure—a safety and proof-of-concept study.
        Chest. 2012; 142: 927-934
        • Zhang X.L.
        • Ding N.
        • Ni B.
        • et al.
        Safety and feasibility of chronic transvenous phrenic nerve stimulation for the treatment of central sleep apnea in heart failure patients.
        Clin Respir J. 2015; https://doi.org/10.1111/crj. 12320
        • Abraham W.T.
        • Jagielski D.
        • Oldenburg O.
        • et al.
        • On behalf of the remedē® Pilot Study Investigators
        Phrenic nerve stimulation for the treatment of central sleep apnea.
        JACC Heart Fail. 2015; 5: 360-369
        • Costanzo M.R.
        • Augostini R.
        • Goldberg L.R.
        • et al.
        Design of the remedē® system pivotal trial: a prospective, randomized study in the use of respiratory rhythm management to treat central sleep apnea.
        J Card Fail. 2015; 21: 892-902
        • Joranson D.E.
        • Ryan K.M.
        • Gilson A.M.
        • et al.
        Trends in medical use abuse of opioid analgesics.
        JAMA. 2000; 283: 1710-1714
      2. ARCOS. Automation of reports and consolidated orders system Retail drug summary. US Department of Justice; DEA, 2005
      3. Monitoring the future (MTF) survey, US. Services DoHaH, 2005
      4. Unintentional drug poisoning in the United States. National Center for Injury Prevention and Control CfDCaP, 2010
        • Centers for Disease Control and Prevention (CDC)
        Increase in poisoning deaths caused by non-illicit drugs—Utah 1991-2003.
        MMWR Morb Mortal Wkly Rep. 2005; 54: 3-6
        • Javaheri S.
        • Malik A.
        • Smith J.
        • et al.
        Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids.
        J Clin Sleep Med. 2008; 4: 305-310
        • Javaheri S.
        • Harris N.
        • Howard J.
        • et al.
        Adaptive servo-ventilation for treatment of opioids-associated central sleep apnea.
        J Clin Sleep Med. 2014; 10: 637-643
        • Webster L.R.
        • Choi Y.
        • Desai H.
        • et al.
        Sleep-disordered breathing and chronic opioid therapy.
        Pain Med. 2008; 9: 425-432
        • Teichtahl H.
        • Prodromidis A.
        • Miller B.
        • et al.
        Sleep-disordered breathing in stable methadone programme patients: a pilot study.
        Addiction. 2001; 96: 395-403
        • Farney R.J.
        • Walker J.M.
        • Cloward T.V.
        • et al.
        Sleep-disordered breathing associated with long-term opioid therapy.
        Chest. 2003; 123: 632-639
        • Farney R.J.
        • Walker J.M.
        • Boyle K.M.
        • et al.
        Adaptive servoventilation (ASV) in patients with sleep disordered breathing associated with chronic opioid medications for non-malignant pain.
        J Clin Sleep Med. 2008; 4: 311-319
        • Javaheri S.
        • Cao M.
        Opioid induced central sleep apnea.
        in: Fabiani M. Proceedings of the X World Congress on sleep apnea, section: respiratory disorders and snoring. Edizioni Minerva Medica, Turin (Italy)2012: 133-137
        • Cao M.
        • Javaheri S.
        Chronic opioid use: effects on respiration and sleep.
        in: Tvildiani D. Gegechkori K. Opioids pharmacology, clinical uses and adverse effects. Nova Science Publishers, Inc, New York2012: 1-13
        • Arora N.
        • Cao M.
        • Javaheri S.
        Opioids, sedatives, and sleep hypoventilation.
        Sleep Med Clin. 2014; 9: 391-398
        • Javaheri S.
        • Smith J.
        • Chung J.
        The prevalence and natural history of complex sleep apnea.
        J Clin Sleep Med. 2009; 5: 205-211
        • Allam J.S.
        • Olson E.J.
        • Gay P.C.
        • et al.
        Efficacy of adaptive servoventilation in treatment of complex and central sleep apnea syndromes.
        Chest. 2007; 132: 1839-1846
        • Cao M.
        • Cardell C.Y.
        • Willes L.
        • et al.
        A novel adaptive servoventilation (ASVAuto) for the treatment of central sleep apnea associated with chronic use of opioids.
        J Clin Sleep Med. 2014; 10: 855-861
        • Troitino A.
        • Labedi N.
        • Kufel T.
        • et al.
        Positive airway pressure therapy in patients with opioid-related central sleep apnea.
        Sleep Breath. 2014; 18: 367-373
        • Guilleminault C.
        • Cao M.
        • Yue H.J.
        • et al.
        Obstructive sleep apnea and chronic opioid use.
        Lung. 2010; 188: 459-468
        • Ren J.
        • Poon B.Y.
        • Tang Y.
        • et al.
        Ampakines alleviate respiratory depression in rats.
        Am J Respir Crit Care Med. 2006; 174: 1384-1391
        • Ren J.
        • Ding X.
        • Funk G.D.
        • et al.
        Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats.
        Anesthesiology. 2009; 110: 1364-1370
        • Ren J.
        • Ding X.
        • Greer J.J.
        Respiratory depression in rats induced by alcohol and barbiturate and alleviation by ampakine CX717.
        J Appl Physiol (1985). 2012; 113: 1004-1011
        • Ren J.
        • Lenal F.
        • Yang M.
        • et al.
        Co-administration of the ampakine CX717 with propofol reduces respiratory depression and fatal apneas.
        Anesthesiology. 2013; 118: 1437-1445
        • Ren J.
        • Ding X.
        • Greer J.J.
        Ampakines enhance weak endogenous respiratory drive and apnea in perinatal rats.
        Am J Respir Crit Care Med. 2015; 191: 704-710
        • El Mallah M.K.
        • Pagliardini S.
        • Turner S.M.
        • et al.
        Stimulation of respiratory motor output and ventilation in a murine model of Pompe disease by ampakines.
        Am J Respir Cell Mol Biol. 2015; 53: 326-335
        • Oertel B.G.
        • Felden L.
        • Tran P.V.
        • et al.
        Selective antagonism of opioid-induced respiratory depression by an AMPAKINE molecule in humans without loss of opioid analgesia.
        Clin Pharmacol Ther. 2010; 87: 204-211
        • Greer J.J.
        • Smith J.C.
        • Feldman J.L.
        The role of excitatory amino acids in the generation and transmission of respiratory drive in the neonatal rat.
        J Physiol. 1991; 1001: 727-749
        • Ge Q.
        • Feldman J.L.
        AMPA receptor activation and phosphatase inhibition affect neonatal rat respiratory rhythm generation.
        J Physiol. 1998; 509: 255-266
        • Funk G.D.
        • Smith J.C.
        • Feldman J.L.
        Generation and transmission of respiratory oscillations in medullary slices: role of excitatory amino acids.
        J Neurophysiol. 1993; 70: 1497-1515
        • Pace R.W.
        • Mackay D.D.
        • Feldman J.L.
        • et al.
        Inspiratory bursts in the preBötzinger complex depend on a calcium-activated non-specific cation current linked to glutamate receptors in neonatal mice.
        J Physiol. 2007; 582: 113-125
        • Liu G.
        • Feldman J.L.
        • Smith J.C.
        Excitatory amino acid-mediated transmission of inspiratory drive to phrenic motoneurons.
        J Neurophysiol. 1990; 64: 423-436
        • Chitravanshi V.C.
        • Sapru H.N.
        NMDA as well as non-NMDA receptors mediate the neurotransmission of inspiratory drive to phrenic motoneurons in the adult rat.
        Brain Res. 1996; 715: 104-112
        • Lynch G.
        Glutamate-based therapeutic approaches: ampakines.
        Curr Opin Pharmacol. 2006; 6: 82-88
        • Lynch G.
        • Gall C.M.
        Ampakines and the threefold path to cognitive enhancement.
        Trends Neurosci. 2006; 29: 554-562
        • Arai A.C.
        • Xia Y.F.
        • Suzuki E.
        Modulation of AMPA receptor kinetics differentially influences synaptic plasticity in the hippocampus.
        Neuroscience. 2004; 123: 1011-1024
        • Greer J.J.
        • Smith J.C.
        • Feldman J.L.
        Generation of respiratory and locomotor patterns by an in vitro brainstem-spinal cord fetal rat preparation.
        J Neurophysiol. 1992; 67: 996-999
        • Smith J.C.
        • Greer J.J.
        • Liu G.
        • et al.
        Neural mechanisms generating respiratory pattern in mammalian brainstem-spinal cord in vitro. I. Spatiotemporal patterns of motor and medullary neuron activity.
        J Neurophysiol. 1990; 64: 1149-1169
        • Smith J.C.
        • Ellenberger H.H.
        • Ballanyi K.
        • et al.
        PreBötzinger complex: a brainstem region that may generate respiratory rhythm in mammals.
        Science. 1991; 1001: 726-729
        • Lorier A.L.
        • Funk G.L.
        • Greer J.J.
        Opiate-induced suppression of rat hypoglossal motoneuron activity and its reversal by ampakine therapy.
        PLoS One. 2010; 5: e8766